Wird geladen...
An Update on Anti-IgE Therapy in Pediatric Respiratory Diseases
Anti-IgE treatment represents a major breakthrough in the therapeutic management of severe allergic asthma. Omalizumab is the unique biologic treatment registered for asthma therapy in children. The clinical efficacy and safety of omalizumab treatment in the pediatric population has been extensively...
Gespeichert in:
| Veröffentlicht in: | Curr Respir Med Rev |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Bentham Science Publishers
2017
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5735517/ https://ncbi.nlm.nih.gov/pubmed/29290750 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2174/1573398X13666170616110738 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|